Jobs

Currently 874 Medical Comms jobs

Candidates Login

CV Database

Let the jobs come to you!

Company Login

Site Newsletter

Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

PharmiWeb on Facebook

Advertising

Press Releases

submit a press release

81 Press Releases

1 2 3

Date	Title	Company
30 Apr 13	Ligand Acquires Financial Rights to More Than 15 Fully-Funded Development Programs from Selexis SA	Ligand Pharmaceuticals Incorporated, Published by Business Wire
26 Apr 13	Ligand Presents Preclinical Data on HepDirect™ Liver-Targeting Technology Platform at 2013 International Liver Congress (EASL) Annual Meeting	Ligand Pharmaceuticals Incorporated, Published by Business Wire
23 Apr 13	Ligand to Present at Upcoming Investor Conferences	Ligand Pharmaceuticals Incorporated, Published by Business Wire
22 Apr 13	Ligand to Report First Quarter Results on May 8th	Ligand Pharmaceuticals Incorporated, Published by Business Wire
25 Feb 13	Ligand Receives $1.4 Million Milestone Payment from Retrophin, Inc.	Ligand Pharmaceuticals Incorporated, Published by Business Wire
14 Feb 13	Ligand Reports Fourth Quarter and Full Year 2012 Financial Results	Ligand Pharmaceuticals Incorporated, Published by Business Wire
23 Jan 13	Ligand to Report Fourth Quarter Results on February 13th	Ligand Pharmaceuticals Incorporated, Published by Business Wire
09 Jan 13	Ligand Receives Equity Milestone Payment from Retrophin	Ligand Pharmaceuticals Incorporated, Published by Business Wire
14 Dec 12	U.S. Food and Drug Administration (FDA) Accepts New Drug Application For Bazedoxifene/Conjugated Estrogens, An Investigational Treatment For Symptoms Associated With Menopause And Prevention of Osteoporosis	Ligand Pharmaceuticals Incorporated, Published by Business Wire
11 Dec 12	Ligand Initiates Pivotal Trial of Captisol-Enabled®, Propylene Glycol-Free Melphalan in Patients with Multiple Myeloma	Ligand Pharmaceuticals Incorporated, Published by Business Wire
04 Dec 12	Ligand to Present Growth Prospects, Review Key Portfolio Assets and Introduce Financial Guidance at Analyst Day Event	Ligand Pharmaceuticals Incorporated, Published by Business Wire
27 Nov 12	Reminder: Ligand to Host Analyst Day on December 4th in New York City	Ligand Pharmaceuticals Incorporated, Published by Business Wire
19 Nov 12	Ligand Partner GlaxoSmithKline Receives FDA Approval for New Indication for PROMACTA® (eltrombopag)	Ligand Pharmaceuticals Incorporated, Published by Business Wire
13 Nov 12	Ligand Announces Positive Preclinical Data on HepDirect™ Liver-Targeted Antiviral for the Treatment of Hepatitis C	Ligand Pharmaceuticals Incorporated, Published by Business Wire
06 Nov 12	Ligand Pharmaceuticals to Restate Previous Financial Statements	Ligand Pharmaceuticals Incorporated, Published by Business Wire
06 Nov 12	Ligand Pharmaceuticals Reports Preliminary Third Quarter 2012 Results	Ligand Pharmaceuticals Incorporated, Published by Business Wire
01 Nov 12	Ligand to Host Analyst Day on December 4th in New York City	Ligand Pharmaceuticals Incorporated, Published by Business Wire
22 Oct 12	Ligand to Report Third Quarter Results on November 5th	Ligand Pharmaceuticals Incorporated, Published by Business Wire
22 Oct 12	Ligand to Receive $2 Million Milestone Payment from Merck Triggered by Initiation of Phase 2b/3 Trial of Dinaciclib	Ligand Pharmaceuticals Incorporated, Published by Business Wire
25 Jul 12	Ligand Partner GlaxoSmithKline Announces Priority Review for Supplemental New Drug Application for Promacta® for the Treatment of Thrombocytopenia in Adult Patients with Chronic Hepatitis C Infection	Ligand Pharmaceuticals Incorporated, Published by Business Wire
21 Jul 12	Ligand Licensee Onyx Pharmaceuticals Receives FDA Accelerated Approval of Kyprolis™ (carfilzomib) for Injection	Ligand Pharmaceuticals Incorporated, Published by Business Wire
19 Jul 12	Ligand Partner Pfizer Announces European Medicines Agency Accepts Regulatory Submission for Bazedoxifene/Conjugated Estrogens for the Treatment of Symptoms Associated with Menopause and Osteoporosis	Ligand Pharmaceuticals Incorporated, Published by Business Wire
09 Jul 12	Ligand Announces New Presentation Time at the JMP Securities 7th Annual Healthcare Conference	Ligand Pharmaceuticals Incorporated, Published by Business Wire
28 Jun 12	Ligand to Present at the JMP Securities 7th Annual Healthcare Conference	Ligand Pharmaceuticals Incorporated, Published by Business Wire
11 Jun 12	Ligand Announces Positive Preclinical Data on LGD-6972 at the American Diabetes Association’s 72nd Scientific Sessions	Ligand Pharmaceuticals Incorporated, Published by Business Wire
30 May 12	Ligand Partner GlaxoSmithKline Submits US and European Regulatory Applications for use of PROMACTA/REVOLADE to Increase Platelet Counts in Patients with Hepatitis C	Ligand Pharmaceuticals Incorporated, Published by Business Wire
14 May 12	CORRECTING and REPLACING Ligand to Present at the Jefferies 2012 Global Healthcare Conference on June 4	Ligand Pharmaceuticals Incorporated, Published by Business Wire
14 May 12	Ligand to Present at the Jefferies 2011 Global Healthcare Conference on June 4	Ligand Pharmaceuticals Incorporated, Published by Business Wire
08 May 12	Ligand to Present at the Bank of America Merrill Lynch 2012 Health Care Conference on May 17	Ligand Pharmaceuticals Incorporated, Published by Business Wire
16 Apr 12	Ligand to Report First Quarter Results on May 2nd	Ligand Pharmaceuticals Incorporated, Published by Business Wire

1 2 3

subscribe in a reader

Advertising

Share | | |

Site Map
Privacy & Security
Cookies
Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.